A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)

Recruiting

Phase 2

A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)

Sponsor:

Memorial Sloan Kettering Cancer Center

Code:

NCT05307939

Conditions

HPV

Oropharynx Cancer

HPV-Related Carcinoma

HPV-Related Malignancy

HPV Positive Oropharyngeal Squamous Cell Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

HPV ctDNA Assay

MRI Studies

EORTC QLQ H&N 35 and C30

MDADI-HN

COST-FACIT

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center on 2025-05-18.